We are live on ! Find out more
DWM

Dynasty Wealth Management Portfolio holdings

AUM $11.5B
1-Year Est. Return 15.23%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
+15.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.2B
AUM Growth
+$2.69B
Cap. Flow
+$2.59B
Cap. Flow %
25.46%
Top 10 Hldgs %
49.2%
Holding
355
New
52
Increased
206
Reduced
77
Closed
19

Sector Composition

Rank Sector Weight
1 Technology 1.44%
2 Financials 0.68%
3 Healthcare 0.43%
4 Communication Services 0.42%
5 Consumer Discretionary 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGRO icon
226
iShares Core Dividend Growth ETF
DGRO
$43.4B
$582K 0.01%
8,380
+524
+7% +$36K
TS icon
227
Tenaris
TS
$28.8B
$571K 0.01%
14,848
+1,780
+14% +$68.6K
ARGX icon
228
argenx
ARGX
$54.3B
$570K 0.01%
678
+41
+6% +$35.1K
BSV icon
229
Vanguard Short-Term Bond ETF
BSV
$44.6B
$563K 0.01%
7,140
-4,879
-41% -$385K
UL icon
230
Unilever
UL
$139B
$562K 0.01%
8,595
+5,117
+147% +$344K
FUTU icon
231
Futu Holdings
FUTU
$15.5B
$552K 0.01%
3,362
+96
+3% +$16.5K
PANW icon
232
Palo Alto Networks
PANW
$296B
$551K 0.01%
2,994
+309
+12% +$62.3K
AMGN icon
233
Amgen
AMGN
$220B
$550K 0.01%
1,682
+106
+7% +$33.6K
FMHI icon
234
First Trust Municipal High Income ETF
FMHI
$999M
$547K 0.01%
11,421
+137
+1% +$6.57K
CL icon
235
Colgate-Palmolive
CL
$74.4B
$540K 0.01%
+6,831
New +$536K
HLI icon
236
Houlihan Lokey
HLI
$8.96B
$540K 0.01%
3,098
-11
-0.4% -$2.02K
PAYC icon
237
Paycom
PAYC
$8.15B
$539K 0.01%
3,381
+121
+4% +$21.4K
GILD icon
238
Gilead Sciences
GILD
$164B
$525K 0.01%
+4,280
New +$520K
COKE icon
239
Coca-Cola Consolidated
COKE
$12.3B
$511K 0.01%
3,332
+506
+18% +$74.2K
RS icon
240
Reliance Steel & Aluminium
RS
$21.5B
$495K ﹤0.01%
+1,715
New +$482K
HMC icon
241
Honda
HMC
$39.7B
$488K ﹤0.01%
16,565
+2,022
+14% +$61.4K
NU icon
242
Nu Holdings
NU
$69.9B
$477K ﹤0.01%
28,508
+1,285
+5% +$20.7K
TM icon
243
Toyota
TM
$220B
$476K ﹤0.01%
2,222
+560
+34% +$114K
BX icon
244
Blackstone
BX
$109B
$469K ﹤0.01%
3,045
-230
-7% -$35K
VRTX icon
245
Vertex Pharmaceuticals
VRTX
$123B
$459K ﹤0.01%
+1,013
New +$437K
WDS icon
246
Woodside Energy
WDS
$41.9B
$455K ﹤0.01%
29,167
+982
+3% +$15.6K
MMM icon
247
3M
MMM
$93.9B
$452K ﹤0.01%
2,823
+874
+45% +$143K
HELO icon
248
JPMorgan Hedged Equity Laddered Overlay ETF
HELO
$4.7B
$445K ﹤0.01%
6,692
+6
+0.1% +$394
UNH icon
249
UnitedHealth
UNH
$375B
$437K ﹤0.01%
1,324
+518
+64% +$176K
GRFS
250
Grifois
GRFS
$5.4B
$437K ﹤0.01%
46,747
+305
+0.7% +$2.77K

Similar funds

Dynasty Wealth Management's Q4 2025 Portfolio in Review

As of Q4 2025, Dynasty Wealth Management held 355 positions worth $10.2B, up 36% from $7.49B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Dynasty Wealth Management deployed $2.59B of net new capital in Q4 2025, opening 52 new positions and adding to 206 existing holdings. Its largest new stake was iShares A.I. Innovation and Tech Active ETF: 11,940,004 shares worth $398M.

By sector, the portfolio is most concentrated in Technology at 1.4% of assets, down from 1.9% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI USA Quality Factor ETF, an estimated $81.4M trimmed.

  • Dynasty Wealth Management's largest Q4 2025 buy was iShares A.I. Innovation and Tech Active ETF: 11,940,004 shares worth $398M.
  • Dynasty Wealth Management added most to iShares Russell 1000 Growth ETF in Q4 2025, an estimated $295M increase.
  • Dynasty Wealth Management's biggest Q4 2025 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $81.4M.
  • Dynasty Wealth Management fully exited PIMCO Short Term Municipal Bond Active Exchange-Traded Fund in Q4 2025, selling an estimated $40M.
  • Dynasty Wealth Management's ten largest holdings make up 49% of its $10.2B portfolio in Q4 2025.
  • Dynasty Wealth Management opened 52 new positions and closed 19 in Q4 2025.
  • Dynasty Wealth Management's portfolio value rose 36% quarter-over-quarter to $10.2B.

Based on Dynasty Wealth Management's 13F filing for Q4 2025, filed 10 Feb 2026.